Guardant Health
GH
#1306
Rank
S$22.20 B
Marketcap
S$167.45
Share price
4.19%
Change (1 day)
162.88%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: S$22.20 Billion

As of June 2026 Guardant Health has a market cap of S$22.20 Billion. This makes Guardant Health the world's 1306th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$22.20 B29.3%
2025S$17.17 B235.89%
2024S$5.11 B17.89%
2023S$4.33 B16.09%
2022S$3.73 B-72.83%
2021S$13.74 B-19.36%
2020S$17.04 B72.3%
2019S$9.89 B124.64%
2018S$4.40 B

End of Day market cap according to different sources

On Jun 9th, 2026 the market cap of Guardant Health was reported to be:

S$22.20 Billion
by Nasdaq info icon info icon
S$22.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
S$2.60 B-88.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S$41.06 B 84.95%๐Ÿ‡บ๐Ÿ‡ธ USA